In an ulcerative colitis-like DSS chemical colitis model, treatment with SP600125, a pan JNK inhibitor with affinity in the nanomolar range, and an inhibition of JNK resulted in a significant reduction in histopathological scores. This evidence concerns the gene MAPK8 and colitis.